All Engineering Articles
  • Fabricated green building products rapidly advancing

    Don Rosato Engineering

    Green building technology redefines how we make and live in buildings. From a plastics processing standpoint, we can both reduce a building's energy consumption and simultaneously provide for a building's energy production.

  • Afghanistan at a crossroads for future oil and gas extraction

    Stefanie Heerwig Natural Resources

    At the beginning of October, Afghanistan's Ministry of Mines and Petroleum released a new tender for a block in the prospective Amu-Darya basin at the northern tip of the country. China's giant state-owned oil and gas company, CNPC, already holds two blocks in that basin and started extracting oil at the end of last year. Twelve years after the invasion into Afghanistan, the country finds itself at the crossroads to a promising future thanks to its riches in oil, gas and other natural resources.

  • A new path for SDN: Routing and switches are not commodities

    Victor Blake

    During my tenure at a large service provider, someone in the purchasing department decided that all network equipment purchases were commodities to be bid out like the purchasing of pencils, pens and paper. Suffice it to say that even fiber-optic cables were not then commodities, and certainly not IP routers and switches.

  • Emerging green building material technologies to watch

    Don Rosato

    "Green building" is being transformed from a buzzword to a sophisticated approach using technology that redefines how we make and live in buildings that both reduce building energy consumption and provide for building energy production.

  • At the cutting edge of environmentally advanced cooling

    Andrew Gaved

    ​Our recent Cooling Industry Awards once again provided refrigeration and air conditioning suppliers the opportunity to demonstrate their environmentally advanced innovations.

  • Netflix is just HBO minus the delivery

    Mitch Weinraub

    I don't know about you, but the next time I hear or read that "Netflix is killing pay TV," I'm going to scream. Anyone who takes a step back will realize that Netflix is pay TV. Netflix is a competitor to HBO, Showtime and Starz. They all offer different (but similar) collections of feature films, episodic programming and original content. Content-wise, it is only a difference in quantity, quality and price. They all allow programming to be watched on large screens and mobile devices, although some services are better at one than the other.

  • Contract transparency: A win-win situation

    Stefanie Heerwig

    Contract transparency is increasingly advocated as a tool to achieve good governance in the extractive industries around the globe. Those opposing contract transparency argue that if the practice is not implemented consistently, nontransparent companies will have an advantage to transparent ones, and nontransparent countries will attract more investment compared to transparent ones.

  • Hollow-tube steel: An effective weapon in the war against corrosion

    Sasha Viasasha

    ​Perhaps the most villainous enemies of commercial building projects are the two most basic elements of our environment: air and water. In response, urban planners have deployed a material that has shown some promising results as an inhibitor to oxidation. Sites around the world, from France to Japan, have successfully used hollow-tube steel in construction projects, and some have lasted for decades in extremely corrosive environments.

  • High-end highlights from CEDIA 2013

    Mitch Weinraub

    In September, Denver hosted the annual CEDIA (The Custom Electronic Design & Installation Association) conference. This show focuses on high end electronics and home theater installations with everything from the mild to the extremely wild. While a number of exhibitors showed items that will likely never make it to the mass market, others serve as a preview of what, as prices decrease, will soon become available to the masses.

  • Is startup biotech funding at risk?

    Mike Wokasch

    Over the past couple of decades, small biotech companies have been an invaluable source of exciting new drug treatments. As a result, investors have been handsomely rewarded for funding these high-risk, speculative technologies that helped fill depleted Big Pharma pipelines. Companies with any hope for delivering a return on investor money have two possibilities; have one of their technologies acquired or have the entire company acquired by a cash rich Big Pharma or Big Biotech.